Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

What is Genetic Engineering?

What is Genetic Engineering?

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Embryonic Stem Cells

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Single-Cell RNA-Seq Reveals Conserved Cellular Communication Mechanisms Governing Ocular Lineage Specification from Human iPS Cells.

Cells·2026

Same author

The TCF4 Gene Regulates Apoptosis of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy.

Investigative ophthalmology & visual science·2025

Same author

Single-cell transcriptomics reveals the molecular basis of human iPS cell differentiation into ectodermal ocular lineages.

Communications biology·2024

Same author

Misfolding of fukutin-related protein (FKRP) variants in congenital and limb girdle muscular dystrophies.

Frontiers in molecular biosciences·2024

Same author

Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate Data.

Journal of clinical medicine·2022

Same author

CMYA5 is a novel interaction partner of FHL2 in cardiac myocytes.

The FEBS journal·2022

Same journal

Energy crops for biofuel feedstocks: facts and recent patents on genetic manipulation to improve biofuel crops.

Recent patents on DNA & gene sequences·2014

Same journal

Functional genome-wide analysis: a technical review, its developments and its relevance to cancer research.

Recent patents on DNA & gene sequences·2013

Same journal

Recent advances in gene therapy of endometriosis.

Recent patents on DNA & gene sequences·2013

Same journal

Biotechnological advances in amaranths species and their future outlook in crop improvement--a review.

Recent patents on DNA & gene sequences·2013

Same journal

Patent landscape for biological hydrogen production.

Recent patents on DNA & gene sequences·2013

Same journal

Patented aptamers for C-reactive protein detection: a review about their use in clinical diagnostics.

Recent patents on DNA & gene sequences·2013

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

Patenting human genes and stem cells.

Enca Martin-Rendon¹, Derek J Blake

¹Stem Cell Research Laboratory, NHS Blood and Transplant, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK. enca.martin-rendon@nbs.nhs.uk

Recent Patents on DNA & Gene Sequences

|December 17, 2008

Summary

This summary is machine-generated.

Patents on stem cells are growing, despite legal debates over ownership. Advances in gene editing and reprogramming are driving innovation in stem cell therapeutics.

More Related Videos

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions

Published on: November 26, 2014

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

Related Experiment Videos

Last Updated: Jun 27, 2026

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions

Derivation and Characterization of a Transgene-free Human Induced Pluripotent Stem Cell Line and Conversion into Defined Clinical-grade Conditions

Published on: November 26, 2014

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

Area of Science:

Biotechnology
Intellectual Property Law
Regenerative Medicine

Background:

Cell lines and genetically modified organisms have been patentable for two decades.
Stem cell research faces legal and social controversies regarding ownership, impacting therapeutic commercialization.
Despite broad patent claims, stem cell patent applications are increasing exponentially.

Purpose of the Study:

To review recent patents concerning stem cell pluripotency genes.
To summarize advancements in gene transfer into stem cells.
To examine patents related to genetic reprogramming of stem cells.

Main Methods:

Review of published patents on pluripotency genes.
Analysis of gene transfer technologies for stem cells.
Examination of genetic reprogramming patents.
Focus on hematopoietic and embryonic stem cells as model systems.

Main Results:

Exponential growth in stem cell patent applications.
Identification of key pluripotency genes.
Advancements in genetic manipulation and reprogramming technologies.
Broad patent claims may hinder therapeutic commercialization.

Conclusions:

Stem cell patenting is a rapidly expanding field.
Technological advancements are enhancing stem cell manipulation.
Navigating patent landscapes is crucial for stem cell therapeutic development.